Patents by Inventor Thomas F. Baumert

Thomas F. Baumert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE ASSESSMENT OF RISK AND TREATMENTS FOR LIVER CANCERS AND LETHAL LIVER DISEASE COMPLICATIONS
    Publication number: 20230073981
    Abstract: Disclosures herein are directed to methods and compositions for predicting high- and low-risk liver disease in patients. Based on the results achieved from the methods and compositions disclosed herein, liver disease patients can be classified into a prognostic risk group, which enables early diagnosis and prevention of HCC and other lethal complications. Methods and compositions disclosed herein substantially improve the poor prognosis of subjects having or at risk for one or more liver diseases.
    Type: Application
    Filed: August 26, 2022
    Publication date: March 9, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Yujin Hoshida, Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert
  • Synthesis and purification of hepatitis C virus-like particles
    Patent number: 6387662
    Abstract: Production of enveloped RNA virus-like particles intracellularly in vitro in insect cells using a recombinant baculovirus vector containing a cDNA coding for viral structural proteins is disclosed. In vitro production and purification of hepatitis C virus (HCV)-like particles containing HCV core protein, E1 protein and E2 protein is disclosed. Production of antibodies in vivo to the purified HCV-like particles is disclosed.
    Type: Grant
    Filed: April 21, 1999
    Date of Patent: May 14, 2002
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: T. Jake Liang, Thomas F. Baumert